In Vitro Activities of Broad-Spectrum Cephalosporins against Nonmeningeal Isolates of Streptococcus pneumoniae: MIC Interpretation Using NCCLS M100-S12 Recommendations

Схожие документы

• Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmeningeal isolates of <it>Streptococcus pneumoniae </it>by clinical laboratories in the United States during 2002 and 2003
  по: Thornsberry Clyde, et al.
  Опубликовано: (2004-01-01)
• Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmeningeal isolates of Streptococcus pneumoniae by clinical laboratories in the United States during 2002 and 2003
  по: Master, Ronald N, et al.
  Опубликовано: (2004)
• Impact of Modified Nonmeningeal Streptococcus pneumoniae Interpretive Criteria (NCCLS M100-S12) on the Susceptibility Patterns of Five Parenteral Cephalosporins: Report from the SENTRY Antimicrobial Surveillance Program (1997 to 2001)
  по: Jones, Ronald N., et al.
  Опубликовано: (2002)
• Levofloxacin-Resistant Streptococcus pneumoniae: Second Look
  по: Thornsberry, Clyde, et al.
  Опубликовано: (2001)
• Reinterpretation of Susceptibility Data Using Current NCCLS Breakpoint Criteria
  по: Jones, Mark E., et al.
  Опубликовано: (2003)